Furthermore, lncRNA FTX has emerged as a promising therapeutic target for preserving or restoring pancreatic β-cell function, offering a potential RNA-based intervention for IUGR and its associated metabolic disorders, such as GDM. Here, FTX is linked to metabolic disease.